KEYWORDS
Technology and Procedures, Molecular Testing, Serologic Tests, Treatment Considerations, Combination Therapy, Therapy Sequence, Biological Therapies, Checkpoint Inhibitor, Immunotherapy, Women’s Health, Adverse Events, Clinical Practice (Health Services and Quality), Clinical Guidelines, Patient Safety, Quality Improvement, Quality of Care, Diseases, Lymphoid Malignancies, Lymphomas, Measurable Residual Disease, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Research, Translational Research, Clinical Research, Clinical Trials, Health Outcomes Research, Patient-Reported Outcomes, Real-World Evidence, Study Population, Human, Adult, Elderly